Pricing Log in Create free account

GeoVax Labs Inc. (GOVX) vs Kairos Pharma, Ltd. (KAPA)

GeoVax Labs Inc. and Kairos Pharma, Ltd. are both Biotechnology companies. GeoVax Labs Inc. and Kairos Pharma, Ltd. are of similar size ($1.6M and $1.5M). Across the 10 metrics below, Kairos Pharma, Ltd. leads on 6 and GeoVax Labs Inc. on 4.

Valuation

Metric GOVX KAPA Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 n/m 9.40
P/B 0.39 0.36 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.10 0.21 0.66
EV/Sales (0.33) n/m 9.02
Earnings yield (9,086.67%) (399.90%) (32.88%)
Free cash flow yield (2,686.72%) (264.69%) (23.13%)

Profitability

Metric GOVX KAPA Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (891.59%) (113.96%) (51.96%)
Return on assets (408.79%) (104.32%) (46.06%)
Return on invested capital 0.00% (322.91%) 0.00%

Growth

Metric GOVX KAPA Biotechnology median
Revenue growth (TTM) 963.56% — 6.76%
EPS growth (last fiscal year) 81.41% (30.44%) 29.88%
Revenue growth, 5-year CAGR 16.18% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GOVX KAPA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 11.98 4.97
Net debt to EBITDA 0.14 1.65 1.01

Dividend

Metric GOVX KAPA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GOVX KAPA Biotechnology median
Market cap 1.60m 1.54m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack